A61L 2300/63
Crystals
A61L2300/63 (Crystals) appears on 98 US grants and 173 published applications in this corpus.
Search patents in A61L- Granted patents
- 98
- Published applications
- 173
- Assignees
- 71
- Inventors
- 275
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 3 |
| 2003 | 1 | 14 |
| 2004 | 2 | 2 |
| 2005 | 1 | 5 |
| 2006 | 6 | 5 |
| 2007 | 0 | 4 |
| 2008 | 1 | 1 |
| 2009 | 0 | 5 |
| 2010 | 2 | 10 |
| 2011 | 1 | 11 |
| 2012 | 3 | 5 |
| 2013 | 4 | 11 |
| 2014 | 6 | 8 |
| 2015 | 5 | 13 |
| 2016 | 5 | 11 |
| 2017 | 12 | 9 |
| 2018 | 8 | 5 |
| 2019 | 6 | 9 |
| 2020 | 4 | 8 |
| 2021 | 5 | 4 |
| 2022 | 7 | 6 |
| 2023 | 4 | 8 |
| 2024 | 2 | 8 |
| 2025 | 4 | 5 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of nanocrystals for drug delivery from a balloon28 Apr 2026US 12,611,491 B2Boston Scientific Scimed, Inc.
- Polymer-encapsulated drug particles21 Apr 2026US 12,605,342 B2Tonic Medical, Inc.
- Polymer-encapsulated drug particles17 Mar 2026US 12,576,037 B2Tonic Medical, Inc.
- Drug-eluting stent including crystalline cilostazol2 Dec 2025US 12,485,026 B2Otsuka Medical Devices Co., Ltd.
- Porous composites with high-aspect ratio crystals4 Nov 2025US 12,458,732 B2W. L. Gore & Associates, Inc.
- Use of nanocrystals for drug delivery from a balloon10 Sep 2026US 2026/0263662 A1Boston Scientific Scimed, Inc.
- Porous composites with high-aspect ratio crystals12 Feb 2026US 2026/0041820 A1W. L. Gore & Associates, Inc.
- Modified biological bone mineral scaffold doped based on lithium magnesium phosphate10 Jul 2025US 2025/0222170 A1Ningbo Cibei Medical Treatment Appliance Co., Ltd.
- Polymer-encapsulated drug particles3 Jul 2025US 2025/0213491 A1GIE Medical, Inc.
- Systems and methods for internal drug loading for infusion processes8 May 2025US 2025/0144292 A1Eli Lilly and Company
Most cited
By later US patents
- Therapeutic inhibitor of vascular smooth muscle cells152US 6,663,881 B2NeoRx Corporation · 2003
- Anti-microbial materials118US 6,017,553 AWestaim Technologies, Inc. · 2000
- Anti-microbial materials108US 5,958,440 AWestaim Technologies, Inc. · 1999
- Lubricious coatings for substrates104US 6,723,350 B2Nucryst Pharmaceuticals Corp. · 2004
- Multipurpose anti-microbial silastic sheath system for the prevention of device-related infections99US 5,820,607 ABoard of Regents, The University of Texas Systems · 1998